Why the study?
Does increased adherence to antihypertensive agents reduce vascular events, hospitalization, and healthcare costs?
Does increased adherence to antihypertensive agents reduce vascular events, hospitalization, and healthcare costs?
Increased adherence to antihypertensive agents is associated with better health outcomes and economic gains.
Answers are grounded in this paper and cite their sources.
May support adherence monitoring in hypertension; leaves open causal effects of interventions on events.
Low adherence to AH agents is correlated with a higher risk of vascular events, hospitalization, and greater healthcare costs. An increased level of adherence to AH agents should provide a better health status for individuals and a net economic gain.
No takes yet. Share an insight, caveat, or question.
Dragomir et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: